Illumina
Trade Illumina 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About ILMN
Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through the Core Illumina segment, which serves customers in the research, clinical and applied markets fields, and enables the adoption of a variety of genomic solutions.
ILMN Key Statistics
Stock Snapshot
The current Illumina(ILMN) stock price is $135.00, with a market capitalization of 20.69B. The stock trades at a price-to-earnings (P/E) ratio of 31.62.
On 2026-02-03, Illumina(ILMN) stock moved within a range of $135.00 to $143.06. With shares now at $135.00, the stock is trading 0.0% above its intraday low and -5.6% below the session's peak.
Trading activity shows a volume of 2.36M, compared to an average daily volume of 2.18M.
The stock's 52-week range extends from a low of $68.70 to a high of $155.53.
The stock's 52-week range extends from a low of $68.70 to a high of $155.53.
ILMN News
Illumina (ILMN) announced a sequencing agreement with the San Diego Zoo Wildlife Alliance’s Frozen Zoo. The 50-year-old biobank is the world’s most comprehensiv...
Illumina, Inc. recently secured CMS reimbursement for its FDA-approved TruSight Oncology Comprehensive in vitro diagnostic test, effective January 1, 2026, at a...
Advertisement Recent performance context for Illumina stock Illumina (ILMN) has drawn investor attention after a 1-month return of 7.8% and a past 3-month ret...
Analyst ratings
43%
of 23 ratingsMore ILMN News
The latest announcement is out from Illumina ( (ILMN) ). On January 30, 2026, Illumina completed its previously announced acquisition of SomaLogic and related...
Standard BioTools (LAB) announced it has completed the previously announced sale of SomaLogic to Illumina (ILMN) for $350 million in upfront cash and up to $75...